Skip to main content

NextGen Precision Health Neuroscience Seminar – Dec. 2. 2024

The goal of the NextGen Precision Health Neuroscience Science Seminar is to highlight transdisciplinary precision research taking place in the field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

For questions about this event, please reach out to Mackenzie Lynch at lynchmm@health.missouri.edu.

“Deubiquitinating Enzymes in Heart Failure”

Presented by: Taixing Cui, M.D., Ph.D., Fellow of the American Heart Association, Professor, Department of Medical Pharmacology and Physiology

Date: December 2, 2024, 4-5 p.m.

Location: Roy Blunt NextGen Precision Health Building/Atkins Family Seminar Room

*Zoom option available

Register Here

 

Speaker Bio

Dr. Taixing Cui is a tenured professor at Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine. He received his MD and completed his medical residency and fellowship in nephrology in China. He received his PhD and started his research career as an assistant professor in Japan. He then moved to US, starting with a research instructor at Morehouse School of Medicine, a research assistant professor at Michigan University School of Medicine, and a tenure track assistant professor and all the way up to tenured full professor at University of South Carolina School of Medicine prior to joining University of Missouri as a Mizzouforward faculty. His research has focused on exploring novel therapeutic targets for cardiovascular disease. His research has been well funded by American Heart Association (AHA), American Diabetes Association (ADA), US Department of Veterans Affairs (VA), and National Institutes of Health (NIH), and currently supported by a NIH R01, a NIH R03, and a VA Merit Award. He has over 100 publications; several book chapters; and numerous invited talks and seminars. He served or serves on several grant review study sections including NIH R01 grant reviews and the editorial boards of several peer reviewed journals.